12345...10...


Transcranial magnetic stimulation – Wikipedia

Transcranial magnetic stimulation (TMS) is a form of neurostimulation. TMS is a non-invasive procedure in which a changing magnetic field is used to cause electric current to flow in a small targeted region of the brain via electromagnetic induction. During a TMS procedure, a magnetic field generator, or “coil”, is placed on the scalp.[1]:3 The coil is connected to a pulse generator, or stimulator, that delivers a changing electric current to the coil.[2]

TMS is used diagnostically to measure the connection between the central nervous system and skeletal muscle to evaluate damage in a wide variety of disease states, including stroke, multiple sclerosis, amyotrophic lateral sclerosis, movement disorders, and motor neuron diseases.[3]

Evidence suggests it is useful for neuropathic pain[4] and treatment-resistant major depressive disorder.[4][5] A 2015 Cochrane review found that there was not enough evidence to determine its effectiveness in treating schizophrenia.[6] For negative symptoms another review found possible efficacy.[4] As of 2014, all other investigated uses of repetitive TMS have only possible or no clinical efficacy.[4]

Matching the discomfort of TMS to distinguish true effects from placebo is an important and challenging issue that influences the results of clinical trials.[4][7][8][9] Adverse effects of TMS are uncommon, and include fainting and rarely seizure.[7] Other adverse effects of TMS include discomfort or pain, hypomania, cognitive changes, hearing loss, and inadvertent current induction in implanted devices such as pacemakers or defibrillators.[7]

The use of TMS can be divided into diagnostic and therapeutic uses.

TMS can be used clinically to measure activity and function of specific brain circuits in humans.[3] The most robust and widely accepted use is in measuring the connection between the primary motor cortex and a muscle to evaluate damage from stroke, multiple sclerosis, amyotrophic lateral sclerosis, movement disorders, motor neuron disease and injuries and other disorders affecting the facial and other cranial nerves and the spinal cord.[3][10][11][12] TMS has been suggested as a means of assessing short-interval intracortical inhibition (SICI) which measures the internal pathways of the motor cortex but this use has not yet been validated.[13]

For neuropathic pain, for which there is little effective treatment, high-frequency (HF) repetitive TMS (rTMS) appears effective.[4] For treatment-resistant major depressive disorder, HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC) appears effective and low-frequency (LF) rTMS of the right DLPFC has probable efficacy.[4][5] The Royal Australia and New Zealand College of Psychiatrists has endorsed rTMS for treatment resistant MDD.[14] As of October 2008, the US Food and Drug Administration authorized the use of rTMS as an effective treatment for clinical depression.[15]

Although TMS is generally regarded as safe, risks increase for therapeutic rTMS compared to single or paired TMS for diagnostic purposes.[16] In the field of therapeutic TMS, risks increase with higher frequencies.[7]

The greatest immediate risk is the rare occurrence of syncope (fainting) and even less commonly, induced seizures.[7][17]

Other adverse short-term effects of TMS include discomfort or pain, transient induction of hypomania, transient cognitive changes, transient hearing loss, transient impairment of working memory, and induced currents in electrical circuits in implanted devices.[7]

During a transcranial magnetic stimulation (TMS) procedure, a magnetic field generator, or “coil” is placed near the head of the person receiving the treatment.[1]:3 The coil produces small electric currents in the region of the brain just under the coil via electromagnetic induction. The coil is positioned by finding anatomical landmarks on the skull including, but not limited to, the inion or the nasion.[18] The coil is connected to a pulse generator, or stimulator, that delivers electric current to the coil.[2]

Most devices provide a shallow magnetic field that affects neurons mostly on the surface of the brain, delivered with coil shaped like the number eight. Some devices can provide magnetic fields that can penetrate deeper, are used for deep transcranial magnetic stimulation (deep TMS), and have different types of coils including the H-coil the C-core coil, and the circular crown coil; as of 2013 the H coil used in devices made by Brainsway were the most developed.[19]

Theta-burst stimulation (TBS) is a popular protocol, as opposed to stimulation patterns based on other neural oscillation patterns (e.g. alpha-burst) used in transcranial magnetic stimulation. It was originally described by Huang in 2005.[20]The protocol has been used clinically for multiple types of disorders. A specific example, for major depressive disorder with stimulation of both right and left dorsolateral prefrontal cortex (DLPFC) is as follows: The left is stimulated intermediately (iTBS) while the right is inhibited via continuous stimulation (cTBS). In the theta-burst stimulation pattern, 3 pulses are administered at 50Hz, every 200ms. In the intermittent theta burst stimulation pattern (iTBS), a 2-second train of TBS is repeated every 10s for a total of 190s (600 pulses). In the continuous theta burst stimulation paradigm (cTBS), a 40s train of uninterrupted TBS is given (600 pulses).

In a March 2015 publication, Bakker[21] demonstrated with 185 patients evenly divided between the standard 10Hz protocol (30 min) and the theta-burst stimulation, that the outcome (reduction of Ham-D and BDI scores) was the same.

Nexstim obtained 510(k) FDA clearance for the assessment of the primary motor cortex for pre-procedural planning in December 2009[22] and for neurosurgical planning in June 2011.[23]

A number of deep TMS have received FDA 510k clearance to market for use in adults with treatment resistant major depressive disorders.[24][25][26][27][28]

The use of single-pulse TMS was approved by the FDA for treatment of migraines in December 2013.[29] It is approved as a Class II medical device under the “de novo pathway”.[30][31]

In the European Economic Area, various versions of Deep TMS H-coils has CE marking for Alzheimer’s disease,[32] autism,[32] bipolar disorder,[33] epilepsy [34] chronic pain[33] major depressive disorder[33] Parkinson’s disease,[33][35] posttraumatic stress disorder (PTSD),[33] schizophrenia (negative symptoms)[33] and to aid smoking cessation.[32] One review found tentative benefit for cognitive enhancement in healthy people.[36]

In 2013, several commercial health insurance plans in the United States, including Anthem, Health Net, and Blue Cross Blue Shield of Nebraska and of Rhode Island, covered TMS for the treatment of depression for the first time.[37] In contrast, UnitedHealthcare issued a medical policy for TMS in 2013 that stated there is insufficient evidence that the procedure is beneficial for health outcomes in patients with depression. UnitedHealthcare noted that methodological concerns raised about the scientific evidence studying TMS for depression include small sample size, lack of a validated sham comparison in randomized controlled studies, and variable uses of outcome measures.[38] Other commercial insurance plans whose 2013 medical coverage policies stated that the role of TMS in the treatment of depression and other disorders had not been clearly established or remained investigational included Aetna, Cigna and Regence.[39]

Policies for Medicare coverage vary among local jurisdictions within the Medicare system,[40] and Medicare coverage for TMS has varied among jurisdictions and with time. For example:

The United Kingdom’s National Institute for Health and Care Excellence (NICE) issues guidance to the National Health Service (NHS) in England, Wales, Scotland and Northern Ireland. NICE guidance does not cover whether or not the NHS should fund a procedure. Local NHS bodies (primary care trusts and hospital trusts) make decisions about funding after considering the clinical effectiveness of the procedure and whether the procedure represents value for money for the NHS.[45]

NICE evaluated TMS for severe depression (IPG 242) in 2007, and subsequently considered TMS for reassessment in January 2011 but did not change its evaluation.[46] The Institute found that TMS is safe, but there is insufficient evidence for its efficacy.[46]

In January 2014, NICE reported the results of an evaluation of TMS for treating and preventing migraine (IPG 477). NICE found that short-term TMS is safe but there is insufficient evidence to evaluate safety for long-term and frequent uses. It found that evidence on the efficacy of TMS for the treatment of migraine is limited in quantity, that evidence for the prevention of migraine is limited in both quality and quantity.[47]

TMS uses electromagnetic induction to generate an electric current across the scalp and skull.[48][49] A plastic-enclosed coil of wire is held next to the skull and when activated, produces a magnetic field oriented orthogonally to the plane of the coil. The magnetic field passes unimpeded through the skin and skull, inducing an oppositely directed current in the brain that activates nearby nerve cells in much the same way as currents applied directly to the cortical surface.[50]

The path of this current is difficult to model because the brain is irregularly shaped and electricity and magnetism are not conducted uniformly throughout its tissues. The magnetic field is about the same strength as an MRI, and the pulse generally reaches no more than 5 centimeters into the brain unless using deep transcranial magnetic stimulation.[51] Deep TMS can reach up to 6cm into the brain to stimulate deeper layers of the motor cortex, such as that which controls leg motion.[52]

From the BiotSavart law

it has been shown that a current through a wire generates a magnetic field around that wire. Transcranial magnetic stimulation is achieved by quickly discharging current from a large capacitor into a coil to produce pulsed magnetic fields between 2 and 3 T.[53] By directing the magnetic field pulse at a targeted area of the brain, one can either depolarize or hyperpolarize neurons in the brain. The magnetic flux density pulse generated by the current pulse through the coil causes an electric field as explained by the Maxwell-Faraday equation,

This electric field causes a change in the transmembrane current of the neuron, which leads to the depolarization or hyperpolarization of the neuron and the firing of an action potential.[53]

The exact details of how TMS functions are still being explored. The effects of TMS can be divided into two types depending on the mode of stimulation:

MRI images, recorded during TMS of the motor cortex of the brain, have been found to match very closely with PET produced by voluntary movements of the hand muscles innervated by TMS, to 522mm of accuracy.[56]The localisation of motor areas with TMS has also been seen to correlate closely to MEG[57] and also fMRI.[58]

The design of transcranial magnetic stimulation coils used in either treatment or diagnostic/experimental studies may differ in a variety of ways. These differences should be considered in the interpretation of any study result, and the type of coil used should be specified in the study methods for any published reports.

The most important considerations include:

With regard to coil composition, the core material may be either a magnetically inert substrate (i.e., the so-called ‘air-core’ coil design), or possess a solid, ferromagnetically active material (i.e., the so-called ‘solid-core’ design). Solid core coil design result in a more efficient transfer of electrical energy into a magnetic field, with a substantially reduced amount of energy dissipated as heat, and so can be operated under more aggressive duty cycles often mandated in therapeutic protocols, without treatment interruption due to heat accumulation, or the use of an accessory method of cooling the coil during operation. Varying the geometric shape of the coil itself may also result in variations in the focality, shape, and depth of cortical penetration of the magnetic field. Differences in the coil substance as well as the electronic operation of the power supply to the coil may also result in variations in the biophysical characteristics of the resulting magnetic pulse (e.g., width or duration of the magnetic field pulse). All of these features should be considered when comparing results obtained from different studies, with respect to both safety and efficacy.[59]

A number of different types of coils exist, each of which produce different magnetic field patterns. Some examples:

Design variations in the shape of the TMS coils allow much deeper penetration of the brain than the standard depth of 1.52.5cm. Circular crown coils, Hesed (or H-core) coils, double cone coils, and other experimental variations can induce excitation or inhibition of neurons deeper in the brain including activation of motor neurons for the cerebellum, legs and pelvic floor. Though able to penetrate deeper in the brain, they are less able to produce a focused, localized response and are relatively non-focal.[7]

Luigi Galvani did pioneering research on the effects of electricity on the body in the late 1700s, and laid the foundations for the field of electrophysiology.[61] In the 1800s Michael Faraday discovered that an electrical current had a corresponding magnetic field, and that changing one, could change the other.[62] Work to directly stimulate the human brain with electricity started in the late 1800s, and by the 1930s electroconvulsive therapy (ECT) has been developed by Italian physicians Cerletti and Bini.[61] ECT became widely used to treat mental illness and became overused as it began to be seen as a “psychiatric panacea”, and a backlash against it grew in the 1970s.[61] Around that time Anthony T. Barker began exploring use of magnetic fields to alter electrical signalling in the brain, and the first stable TMS devices were developed around 1985.[61][62] They were originally intended as diagnostic and research devices, and only later were therapeutic uses explored.[61][62] The first TMS devices were approved by the FDA in October 2008.[61]

TMS research in animal studies is limited due to early FDA approval of TMS treatment of drug-resistant depression. Because of this, there has been no specific coils for animal models. Hence, there are limited number of TMS coils that can be used for animal studies.[63] There are some attempts in the literature showing new coil designs for mice with an improved stimulation profile.[64]

Areas of research include:

It is difficult to establish a convincing form of “sham” TMS to test for placebo effects during controlled trials in conscious individuals, due to the neck pain, headache and twitching in the scalp or upper face associated with the intervention.[4][7] “Sham” TMS manipulations can affect cerebral glucose metabolism and MEPs, which may confound results.[77] This problem is exacerbated when using subjective measures of improvement.[7] Placebo responses in trials of rTMS in major depression are negatively associated with refractoriness to treatment, vary among studies and can influence results.[78]

A 2011 review found that only 13.5% of 96 randomized control studies of rTMS to the dorsolateral prefrontal cortex had reported blinding success and that, in those studies, people in real rTMS groups were significantly more likely to think that they had received real TMS, compared with those in sham rTMS groups.[79] Depending on the research question asked and the experimental design, matching the discomfort of rTMS to distinguish true effects from placebo can be an important and challenging issue.[4][7][8][9]

View original post here:

Transcranial magnetic stimulation – Wikipedia

Posted in Tms

Welcome to TMS

The Minerals, Metals & Materials Society (TMS) is a professional association that connects minerals, metals, and materials scientists and engineers who work in industry, academia, and government positions around the world.

Many of the programs conducted by TMS are made possible by the generous financial support of the American Institute of Mining, Metallurgical, and Petroleum Engineers (AIME).

By using the TMS website you are agreeing to the terms of the TMS Privacy Policy.

Read the original here:

Welcome to TMS

Posted in Tms

Temecula Middle School – Official Site

Help us bring the TMS Library/Media Center into the 21st Century for the 2018/19 School Year. A fundraiser has been createdon DonorsChoose.org posting a supply list of items that will be used in the new Makerspace Section of our library.

What is a Makerspace? It’s an area that offers librarypatrons an opportunity to create intellectual and physical materials using resources such as computers, 3-D printers, audio and video capture and editing tools, and traditional arts and crafts supplies.

To make a donation, visit DonorsChoose.org.

Give to our library by May 11, 2018, and your donation will be doubled thanks to Ripple. Just enter the code RIPPLE during checkout and you’ll be matched dollar for dollar (up to $50).

In return, you’ll get awesome photos of your gift in action and our heartfelt thanks. Please feel free to pass this information along should you know anyone who may want to support our library.

Thank you, in advance, for your support in helping us create this new area of the library for our students.

See the article here:

Temecula Middle School – Official Site

Posted in Tms

Welcome to TMS

The Minerals, Metals & Materials Society (TMS) is a professional association that connects minerals, metals, and materials scientists and engineers who work in industry, academia, and government positions around the world.

Many of the programs conducted by TMS are made possible by the generous financial support of the American Institute of Mining, Metallurgical, and Petroleum Engineers (AIME).

By using the TMS website you are agreeing to the terms of the TMS Privacy Policy.

Read this article:

Welcome to TMS

Posted in Tms

Transcranial magnetic stimulation – Wikipedia

Transcranial magnetic stimulation (TMS) is a form of neurostimulation. TMS is a non-invasive procedure in which a changing magnetic field is used to cause electric current to flow in a small targeted region of the brain via electromagnetic induction. During a TMS procedure, a magnetic field generator, or “coil”, is placed on the scalp.[1]:3 The coil is connected to a pulse generator, or stimulator, that delivers a changing electric current to the coil.[2]

TMS is used diagnostically to measure the connection between the central nervous system and skeletal muscle to evaluate damage in a wide variety of disease states, including stroke, multiple sclerosis, amyotrophic lateral sclerosis, movement disorders, and motor neuron diseases.[3]

Evidence suggests it is useful for neuropathic pain[4] and treatment-resistant major depressive disorder.[4][5] A 2015 Cochrane review found that there was not enough evidence to determine its effectiveness in treating schizophrenia.[6] For negative symptoms another review found possible efficacy.[4] As of 2014, all other investigated uses of repetitive TMS have only possible or no clinical efficacy.[4]

Matching the discomfort of TMS to distinguish true effects from placebo is an important and challenging issue that influences the results of clinical trials.[4][7][8][9] Adverse effects of TMS are uncommon, and include fainting and rarely seizure.[7] Other adverse effects of TMS include discomfort or pain, hypomania, cognitive changes, hearing loss, and inadvertent current induction in implanted devices such as pacemakers or defibrillators.[7]

The use of TMS can be divided into diagnostic and therapeutic uses.

TMS can be used clinically to measure activity and function of specific brain circuits in humans.[3] The most robust and widely accepted use is in measuring the connection between the primary motor cortex and a muscle to evaluate damage from stroke, multiple sclerosis, amyotrophic lateral sclerosis, movement disorders, motor neuron disease and injuries and other disorders affecting the facial and other cranial nerves and the spinal cord.[3][10][11][12] TMS has been suggested as a means of assessing short-interval intracortical inhibition (SICI) which measures the internal pathways of the motor cortex but this use has not yet been validated.[13]

For neuropathic pain, for which there is little effective treatment, high-frequency (HF) repetitive TMS (rTMS) appears effective.[4] For treatment-resistant major depressive disorder, HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC) appears effective and low-frequency (LF) rTMS of the right DLPFC has probable efficacy.[4][5] The Royal Australia and New Zealand College of Psychiatrists has endorsed rTMS for treatment resistant MDD.[14] As of October 2008, the US Food and Drug Administration authorized the use of rTMS as an effective treatment for clinical depression.[15]

Although TMS is generally regarded as safe, risks increase for therapeutic rTMS compared to single or paired TMS for diagnostic purposes.[16] In the field of therapeutic TMS, risks increase with higher frequencies.[7]

The greatest immediate risk is the rare occurrence of syncope (fainting) and even less commonly, induced seizures.[7][17]

Other adverse short-term effects of TMS include discomfort or pain, transient induction of hypomania, transient cognitive changes, transient hearing loss, transient impairment of working memory, and induced currents in electrical circuits in implanted devices.[7]

During a transcranial magnetic stimulation (TMS) procedure, a magnetic field generator, or “coil” is placed near the head of the person receiving the treatment.[1]:3 The coil produces small electric currents in the region of the brain just under the coil via electromagnetic induction. The coil is positioned by finding anatomical landmarks on the skull including, but not limited to, the inion or the nasion.[18] The coil is connected to a pulse generator, or stimulator, that delivers electric current to the coil.[2]

Most devices provide a shallow magnetic field that affects neurons mostly on the surface of the brain, delivered with coil shaped like the number eight. Some devices can provide magnetic fields that can penetrate deeper, are used for deep transcranial magnetic stimulation (deep TMS), and have different types of coils including the H-coil the C-core coil, and the circular crown coil; as of 2013 the H coil used in devices made by Brainsway were the most developed.[19]

Theta-burst stimulation (TBS) is a popular protocol, as opposed to stimulation patterns based on other neural oscillation patterns (e.g. alpha-burst) used in transcranial magnetic stimulation. It was originally described by Huang in 2005.[20] The protocol has been used clinical for multiple types of disorders. A specific example, for major depressive disorder with stimulation of both right and left dorsolateral prefrontal cortex (DLPFC) is as follows: The left is stimulated intermediately (iTBS) while the right is inhibited via continuous stimulation (cTBS). In the theta-burst stimulation pattern, 3 pulses are administered at 50Hz, every 200ms. In the intermittent theta burst stimulation pattern (iTBS), a 2-second train of TBS is repeated every 10s for a total of 190s (600 pulses). In the continuous theta burst stimulation paradigm (cTBS), a 40s train of uninterrupted TBS is given (600 pulses).

In a March 2015 publication, Bakker[21] demonstrated with 185 patients evenly divided between the standard 10Hz protocol (30 min) and the theta-burst stimulation, that the outcome (reduction of Ham-D and BDI scores) was the same.

Nexstim obtained 510(k) FDA clearance for the assessment of the primary motor cortex for pre-procedural planning in December 2009[22] and for neurosurgical planning in June 2011.[23]

A number of deep TMS have received FDA 510k clearance to market for use in adults with treatment resistant major depressive disorders.[24][25][26][27][28]

The use of single-pulse TMS was approved by the FDA for treatment of migraines in December 2013.[29] It is approved as a Class II medical device under the “de novo pathway”.[30][31]

In the European Economic Area, various versions of Deep TMS H-coils has CE marking for Alzheimer’s disease,[32] autism,[32] bipolar disorder,[33] epilepsy [34] chronic pain[33] major depressive disorder[33] Parkinson’s disease,[33][35] posttraumatic stress disorder (PTSD),[33] schizophrenia (negative symptoms)[33] and to aid smoking cessation.[32] One review found tentative benefit for cognitive enhancement in healthy people.[36]

In 2013, several commercial health insurance plans in the United States, including Anthem, Health Net, and Blue Cross Blue Shield of Nebraska and of Rhode Island, covered TMS for the treatment of depression for the first time.[37] In contrast, UnitedHealthcare issued a medical policy for TMS in 2013 that stated there is insufficient evidence that the procedure is beneficial for health outcomes in patients with depression. UnitedHealthcare noted that methodological concerns raised about the scientific evidence studying TMS for depression include small sample size, lack of a validated sham comparison in randomized controlled studies, and variable uses of outcome measures.[38] Other commercial insurance plans whose 2013 medical coverage policies stated that the role of TMS in the treatment of depression and other disorders had not been clearly established or remained investigational included Aetna, Cigna and Regence.[39]

Policies for Medicare coverage vary among local jurisdictions within the Medicare system,[40] and Medicare coverage for TMS has varied among jurisdictions and with time. For example:

The United Kingdom’s National Institute for Health and Care Excellence (NICE) issues guidance to the National Health Service (NHS) in England, Wales, Scotland and Northern Ireland. NICE guidance does not cover whether or not the NHS should fund a procedure. Local NHS bodies (primary care trusts and hospital trusts) make decisions about funding after considering the clinical effectiveness of the procedure and whether the procedure represents value for money for the NHS.[45]

NICE evaluated TMS for severe depression (IPG 242) in 2007, and subsequently considered TMS for reassessment in January 2011 but did not change its evaluation.[46] The Institute found that TMS is safe, but there is insufficient evidence for its efficacy.[46]

In January 2014, NICE reported the results of an evaluation of TMS for treating and preventing migraine (IPG 477). NICE found that short-term TMS is safe but there is insufficient evidence to evaluate safety for long-term and frequent uses. It found that evidence on the efficacy of TMS for the treatment of migraine is limited in quantity, that evidence for the prevention of migraine is limited in both quality and quantity.[47]

TMS uses electromagnetic induction to generate an electric current across the scalp and skull.[48][49] A plastic-enclosed coil of wire is held next to the skull and when activated, produces a magnetic field oriented orthogonally to the plane of the coil. The magnetic field passes unimpeded through the skin and skull, inducing an oppositely directed current in the brain that activates nearby nerve cells in much the same way as currents applied directly to the cortical surface.[50]

The path of this current is difficult to model because the brain is irregularly shaped and electricity and magnetism are not conducted uniformly throughout its tissues. The magnetic field is about the same strength as an MRI, and the pulse generally reaches no more than 5 centimeters into the brain unless using deep transcranial magnetic stimulation.[51] Deep TMS can reach up to 6cm into the brain to stimulate deeper layers of the motor cortex, such as that which controls leg motion.[52]

From the BiotSavart law

it has been shown that a current through a wire generates a magnetic field around that wire. Transcranial magnetic stimulation is achieved by quickly discharging current from a large capacitor into a coil to produce pulsed magnetic fields between 2 and 3 T.[53] By directing the magnetic field pulse at a targeted area of the brain, one can either depolarize or hyperpolarize neurons in the brain. The magnetic flux density pulse generated by the current pulse through the coil causes an electric field as explained by the Maxwell-Faraday equation,

This electric field causes a change in the transmembrane current of the neuron, which leads to the depolarization or hyperpolarization of the neuron and the firing of an action potential.[53]

The exact details of how TMS functions are still being explored. The effects of TMS can be divided into two types depending on the mode of stimulation:

MRI images, recorded during TMS of the motor cortex of the brain, have been found to match very closely with PET produced by voluntary movements of the hand muscles innervated by TMS, to 522mm of accuracy.[56] The localisation of motor areas with TMS has also been seen to correlate closely to MEG[57] and also fMRI.[58]

The design of transcranial magnetic stimulation coils used in either treatment or diagnostic/experimental studies may differ in a variety of ways. These differences should be considered in the interpretation of any study result, and the type of coil used should be specified in the study methods for any published reports.

The most important considerations include:

With regard to coil composition, the core material may be either a magnetically inert substrate (i.e., the so-called ‘air-core’ coil design), or possess a solid, ferromagnetically active material (i.e., the so-called ‘solid-core’ design). Solid core coil design result in a more efficient transfer of electrical energy into a magnetic field, with a substantially reduced amount of energy dissipated as heat, and so can be operated under more aggressive duty cycles often mandated in therapeutic protocols, without treatment interruption due to heat accumulation, or the use of an accessory method of cooling the coil during operation. Varying the geometric shape of the coil itself may also result in variations in the focality, shape, and depth of cortical penetration of the magnetic field. Differences in the coil substance as well as the electronic operation of the power supply to the coil may also result in variations in the biophysical characteristics of the resulting magnetic pulse (e.g., width or duration of the magnetic field pulse). All of these features should be considered when comparing results obtained from different studies, with respect to both safety and efficacy.[59]

A number of different types of coils exist, each of which produce different magnetic field patterns. Some examples:

Design variations in the shape of the TMS coils allow much deeper penetration of the brain than the standard depth of 1.52.5cm. Circular crown coils, Hesed (or H-core) coils, double cone coils, and other experimental variations can induce excitation or inhibition of neurons deeper in the brain including activation of motor neurons for the cerebellum, legs and pelvic floor. Though able to penetrate deeper in the brain, they are less able to produce a focused, localized response and are relatively non-focal.[7]

Luigi Galvani did pioneering research on the effects of electricity on the body in the late 1700s, and laid the foundations for the field of electrophysiology.[61] In the 1800s Michael Faraday discovered that an electrical current had a corresponding magnetic field, and that changing one, could change the other.[62] Work to directly stimulate the human brain with electricity started in the late 1800s, and by the 1930s electroconvulsive therapy has been developed by Italian physicians Cerletti and Bini.[61] ECT became widely used to treat mental illness and became overused as it began to be seen as a “psychiatric panacea”, and a backlash against it grew in the 1970s.[61] Around that time Anthony T. Barker began exploring use of magnetic fields to alter electrical signalling in the brain, and the first stable TMS devices were developed around 1985.[61][62] They were originally intended as diagnostic and research devices, and only later were therapeutic uses explored.[61][62] The first TMS devices were approved by the FDA in October 2008.[61]

TMS research in animal studies is limited due to early FDA approval of TMS treatment of drug-resistant depression. Because of this, there has been no specific coils for animal models. Hence, there are limited number of TMS coils that can be used for animal studies.[63] There are some attempts in the literature showing new coil designs for mice with an improved stimulation profile.[64]

Areas of research include:

It is difficult to establish a convincing form of “sham” TMS to test for placebo effects during controlled trials in conscious individuals, due to the neck pain, headache and twitching in the scalp or upper face associated with the intervention.[4][7] “Sham” TMS manipulations can affect cerebral glucose metabolism and MEPs, which may confound results.[77] This problem is exacerbated when using subjective measures of improvement.[7] Placebo responses in trials of rTMS in major depression are negatively associated with refractoriness to treatment, vary among studies and can influence results.[78]

A 2011 review found that only 13.5% of 96 randomized control studies of rTMS to the dorsolateral prefrontal cortex had reported blinding success and that, in those studies, people in real rTMS groups were significantly more likely to think that they had received real TMS, compared with those in sham rTMS groups.[79] Depending on the research question asked and the experimental design, matching the discomfort of rTMS to distinguish true effects from placebo can be an important and challenging issue.[4][7][8][9]

Follow this link:

Transcranial magnetic stimulation – Wikipedia

Posted in Tms

Welcome to TMS

The Minerals, Metals & Materials Society (TMS) is a professional association that connects minerals, metals, and materials scientists and engineers who work in industry, academia, and government positions around the world.

Many of the programs conducted by TMS are made possible by the generous financial support of the American Institute of Mining, Metallurgical, and Petroleum Engineers (AIME).

By using the TMS website you are agreeing to the terms of the TMS Privacy Policy.

Read more:

Welcome to TMS

Posted in Tms

TMS Maritime Ltd Marine Contractors

TMS Ltd have in excess of25 years of expertise as a Marine Contractor within Civil Engineering . We operate throughout the UK and Europe, where we are able to utilise our unrivalled abilities and professionalism to successfully complete a wide range of marine and civil engineering construction projects

See the original post:

TMS Maritime Ltd Marine Contractors

Posted in Tms

TMS Engineering – Home

TMS Engineering, Inc. is committed to providing the highest quality engineering and consulting services available to our clients while meeting schedule and budget requirements. Through our almost 30 year history, we have successfully upheld this commitment to our clients.

TMS has developed a philosophy and approach to engineering and design that we believe is the most efficient and cost effective for the client. In an effort to make the project a success, TMS makes every effort to understand the project objectives, not simply the engineering objectives. With this information, we can make the most informed and smart decisions during the design phase that will promote a successful project, not just a good engineering package.

Whether working in the preliminary phases of a project such as project scope and cost estimate development, or in the detail design phase, or in the execution phase of the project providing scheduling and planning, project management, or construction management, the staff at TMS Engineering has proven to add value with our practical project approach and hands on philosophy for engineering and consulting.

First and foremost, our emphasis is on quality of service. For large projects or small, TMS Engineering will constantly strive to achieve our ultimate goal:

Follow this link:

TMS Engineering – Home

Posted in Tms

Northern California TMS in California – Cutting Edge …

We are pleased to be able to offer Neurostar TMS Therapy. Transcranial Magnetic Stimulation Therapy is one of the most technologically advanced depression treatments available. This non-invasive, outpatient therapy is FDA approved and has helped thousands of depression patients who have not received adequate results from antidepressants. For an easy to read pdf of the benefits of TMS Therapy, please see here.

See our Depression Self Tests page for questionaires to rate your depression.

More here:

Northern California TMS in California – Cutting Edge …

Posted in Tms

TMS Therapy Center of Tulsa – Cutting Edge Depression …

Dr. Rao has over 20 years of experience treating major depressive disorder. The majority of his patients are people who have had depression for many years, if not for their whole life. Their depression has been recurrent, meaning that it keeps coming back despite treatment; or chronic, meaning that theyve experienced some level of depression, even low-grade baseline depression, that has never lifted; or they are people who say theyve been depressed since their teenage years. The traditional treatment for depression has been psychotherapy, the most effective of which is cognitive behavioral therapy. There are some patients who have great results with this treatment, but not everybody. The second type of treatment for depression is antidepressant medication. Similarly, many patients have great success with this type of treatment but we know from experience that about 50-60% have either an inadequate response or no response at all.

Dr. Rao has expertise in treating recurrent or chronic depression which has not responded to these ordinary treatments. Using new protocols for treating depression with antidepressants and TMS, our patients have a greater-than 60% rate of recovery, meaning full remission of their depressive symptoms. In addition, another 20-30% improve from severe or very severe levels of depression to the mild range with only residual symptoms remaining.

Dr. Rao offers comprehensive evaluation and treatment of clinical depression. Evaluations include complete psychiatric, medical and neurologic histories; medical and neurological examination; and state-of-the-art laboratory testing including genetic testing. Genetic testing can indicate why a patient has not responded to an antidepressant and can suggest what other types of antidepressants the patient might respond to.

TMS is the newest modality available to combat clinical depression. FDA guidelines indicate that TMS therapy is indicated for depressed patients who have undergone a course of psychotherapy and/or a course of 1 or more antidepressants that failed to eliminate the depressive episode. TMS is not a treatment of last resort, but rather a mainstream treatment that can be used routinely along with psychotherapy and medication.

More importantly, TMS has become an important or essential component of treatment of recurrent or chronic depression. Frequently patients who have had only a partial response to antidepressants achieve significant improvement, if not recovery, from depression.

The best candidate for TMS is a patient with clinical depression that has not had a satisfactory response to antidepressants; and/or has not improved with psychotherapy; and/or has experienced intolerable side effects.Mission Statement. The purpose of this Center and its sister practice is to provide outstanding psychiatric care based on the most recent advances in the field, including advances in psychotherapy, psychopharmacology and neuroscience.

See original here:

TMS Therapy Center of Tulsa – Cutting Edge Depression …

Posted in Tms

TMS Worldwide A belgian company operating worldwide!

Message from the TMS Management Team,

Today, Technical Mechanical Services (TMS) has long-term partnerships with end-users involved in construction & mining industries all over the world:

Our goal is a to be a worldwide supply chain provider proposing secured intelligent and alternative 360 solutions to our customers, and being recognised as excellent in the eyes of the customers, employees and the other important stakeholders of the Organisation.

With its headquarters and central warehouse in Lige, Belgium the location is the perfect choice; nearly all the major brands have substantial facilities in the region. The Organization is in partnership with dedicated freight forwarders and therefore is proud to have the capacity to offer multiple shipping methods. We understand our role within the supply chain considerations of our customers.

The organisation does not have an unwieldy hierarchy, but a dynamic corporate culture that represents a no-nonsense approach and efficiency. The level corporate culture leads to smooth communication and a quick decision-making process. At the heart of our corporate culture is our professionalism. In all our strategic development choices, and in the course of our everyday business activities, we are guided by this professionalism and by our entrepreneurial spirit. This is our foremost competitive advantage.

We are driven by the target of creating sustainable value for all its stakeholders. What sets us apart is our ability to develop and maintain mutually beneficial long-term business relationships. With the support of the whole TMS team, we hereby undertake to fulfil the mission of the company and help it realize its vision.

To realize our vision for the future, we need to strive for excellence in everything we do. In a highly competitive market, innovation in the services proposed must be a constant concern. We hereby undertake to encourage the creativity of our staff and the development of their skills by means of appropriate training.

Our excellent reputation is our most important Companys fundamental intangible resource, which represents an element of inward attraction for the best human resources who are interested in operating with our Company. Moreover, good reputation is an element which favours the relationships with business, entrepreneurial and financial partners

The Organization is committed to guaranteeing its Customers satisfaction. It is committed to building true and collaborative relations with them, and sets itself a reliable, qualified and trustworthy partner.

Although our business networks span the globe and our customer base spreads across all 5 continents, our business is tailored to the local needs of ours customers business. Each country has a dedicated team to meet with and support clients.

The TMS Management Team

Services & Products to meet your needs

Continue reading here:

TMS Worldwide A belgian company operating worldwide!

Posted in Tms

Welcome to TMS

The Minerals, Metals & Materials Society (TMS) is a professional association that connects minerals, metals, and materials scientists and engineers who work in industry, academia, and government positions around the world.

Many of the programs conducted by TMS are made possible by the generous financial support of the American Institute of Mining, Metallurgical, and Petroleum Engineers (AIME).

Follow this link:

Welcome to TMS

Posted in Tms

Temecula Middle School: Home Page

Help us bring the TMS Library/Media Center into the 21st Century for the 2018/19 School Year. A fundraiser has been createdon DonorsChoose.org posting a supply list of items that will be used in the new Makerspace Section of our library.

What is a Makerspace? It’s an area that offers librarypatrons an opportunity to create intellectual and physical materials using resources such as computers, 3-D printers, audio and video capture and editing tools, and traditional arts and crafts supplies.

To make a donation, visit DonorsChoose.org.

Give to our library by May 11, 2018, and your donation will be doubled thanks to Ripple. Just enter the code RIPPLE during checkout and you’ll be matched dollar for dollar (up to $50).

In return, you’ll get awesome photos of your gift in action and our heartfelt thanks. Please feel free to pass this information along should you know anyone who may want to support our library.

Thank you, in advance, for your support in helping us create this new area of the library for our students.

See the original post:

Temecula Middle School: Home Page

Posted in Tms

Home – TMS

TMS has a passion for parking, and shows it every day with each and every vehicle entrusted to our care. From parkinglot scouting and layout, to operational planning, ticket sales and real-time inventory, and on-site management, TMS commitment to premium service and delivery shines through to event organizers and attendees alike.

Original post:

Home – TMS

Posted in Tms

TMS – Grow Happiness

We have a new logo and a new look. We are a different kind of company. We speak a different language. We do business in a different way. And were on a mission to Grow Happiness. How do we do it? By believing in Pink Unicorns. Hiring people who live up to the title Wunderwriters. And executing our daily work in a way that allows our customers to experience joydom. Those are the kinds of things that set us apart from everyone else. Click one of the buttons below to see for yourself today.

Read this article:

TMS – Grow Happiness

Posted in Tms

Welcome to TMS

The Minerals, Metals & Materials Society (TMS) is a professional association that connects minerals, metals, and materials scientists and engineers who work in industry, academia, and government positions around the world.

Many of the programs conducted by TMS are made possible by the generous financial support of the American Institute of Mining, Metallurgical, and Petroleum Engineers (AIME).

Excerpt from:

Welcome to TMS

Posted in Tms

Transcranial magnetic stimulation – Wikipedia

Transcranial magnetic stimulation (TMS) is a method in which a changing magnetic field is used to cause electric current to flow in a small region of the brain via electromagnetic induction. During a TMS procedure, a magnetic field generator, or “coil”, is placed near the head of the person receiving the treatment.[1]:3 The coil is connected to a pulse generator, or stimulator, that delivers a changing electric current to the coil.[2]

TMS is used diagnostically to measure the connection between the central nervous system and skeletal muscle to evaluate damage in a wide variety of disease states, including stroke, multiple sclerosis, amyotrophic lateral sclerosis, movement disorders, and motor neuron diseases.[3]

Evidence suggests it is useful for neuropathic pain[4] and treatment-resistant major depressive disorder.[4][5] A 2015 Cochrane review found that there was not enough evidence to determine its effectiveness in treating schizophrenia.[6] For negative symptoms another review found possible efficacy.[4] As of 2014, all other investigated uses of repetitive TMS have only possible or no clinical efficacy.[4]

Matching the discomfort of TMS to distinguish true effects from placebo is an important and challenging issue that influences the results of clinical trials.[4][7][8][9] Adverse effects of TMS are uncommon, and include fainting and rarely seizure.[7] Other adverse effects of TMS include discomfort or pain, hypomania, cognitive changes, hearing loss, and inadvertent current induction in implanted devices such as pacemakers or defibrillators.[7]

The use of TMS can be divided into diagnostic and therapeutic uses.

TMS can be used clinically to measure activity and function of specific brain circuits in humans.[3] The most robust and widely accepted use is in measuring the connection between the primary motor cortex and a muscle to evaluate damage from stroke, multiple sclerosis, amyotrophic lateral sclerosis, movement disorders, motor neuron disease and injuries and other disorders affecting the facial and other cranial nerves and the spinal cord.[3][10][11][12] TMS has been suggested as a means of assessing short-interval intracortical inhibition (SICI) which measures the internal pathways of the motor cortex but this use has not yet been validated.[13]

For neuropathic pain, for which there is little effective treatment, high-frequency (HF) repetitive TMS (rTMS) appears effective.[4] For treatment-resistant major depressive disorder, HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC) appears effective and low-frequency (LF) rTMS of the right DLPFC has probable efficacy.[4][5] The Royal Australia and New Zealand College of Psychiatrists has endorsed rTMS for treatment resistant MDD.[14] As of October 2008, the US Food and Drug Administration authorized the use of rTMS as an effective treatment for clinical depression.[15]

Although TMS is generally regarded as safe, risks increase for therapeutic rTMS compared to single or paired TMS for diagnostic purposes.[16] In the field of therapeutic TMS, risks increase with higher frequencies.[7]

The greatest immediate risk is the rare occurrence of syncope (fainting) and even less commonly, induced seizures.[7][17]

Other adverse short-term effects of TMS include discomfort or pain, transient induction of hypomania, transient cognitive changes, transient hearing loss, transient impairment of working memory, and induced currents in electrical circuits in implanted devices.[7]

During a transcranial magnetic stimulation (TMS) procedure, a magnetic field generator, or “coil” is placed near the head of the person receiving the treatment.[1]:3 The coil produces small electric currents in the region of the brain just under the coil via electromagnetic induction. The coil is positioned by finding anatomical landmarks on the skull including, but not limited to, the inion or the nasion.[18] The coil is connected to a pulse generator, or stimulator, that delivers electric current to the coil.[2]

Most devices provide a shallow magnetic field that affects neurons mostly on the surface of the brain, delivered with coil shaped like the number eight. Some devices can provide magnetic fields that can penetrate deeper, are used for “deep TMS”, and have different types of coils including the H-coil the C-core coil, and the circular crown coil; as of 2013 the H coil used in devices made by Brainsway were the most developed.[19]

Nexstim obtained 510(k) FDA clearance for the assessment of the primary motor cortex for pre-procedural planning in December 2009[20] and for neurosurgical planning in June 2011.[21]

A number of deep TMS have received FDA 510k clearance to market for use in adults with treatment resistant major depressive disorders.[22][23][24][25][26]

The use of single-pulse TMS was approved by the FDA for treatment of migraines in December 2013.[27] It is approved as a Class II medical device under the “de novo pathway”.[28][29]

In the European Economic Area, various versions of Deep TMS H-coils has CE marking for Alzheimer’s disease,[30] autism,[30] bipolar disorder,[31] epilepsy [32] chronic pain[31] major depressive disorder[31] Parkinson’s disease,[31][33] posttraumatic stress disorder (PTSD),[31] schizophrenia (negative symptoms)[31] and to aid smoking cessation.[30] One review found tentative benefit for cognitive enhancement in healthy people.[34]

In 2013, several commercial health insurance plans in the United States, including Anthem, Health Net, and Blue Cross Blue Shield of Nebraska and of Rhode Island, covered TMS for the treatment of depression for the first time.[35] In contrast, UnitedHealthcare issued a medical policy for TMS in 2013 that stated there is insufficient evidence that the procedure is beneficial for health outcomes in patients with depression. UnitedHealthcare noted that methodological concerns raised about the scientific evidence studying TMS for depression include small sample size, lack of a validated sham comparison in randomized controlled studies, and variable uses of outcome measures.[36] Other commercial insurance plans whose 2013 medical coverage policies stated that the role of TMS in the treatment of depression and other disorders had not been clearly established or remained investigational included Aetna, Cigna and Regence.[37]

Policies for Medicare coverage vary among local jurisdictions within the Medicare system,[38] and Medicare coverage for TMS has varied among jurisdictions and with time. For example:

The United Kingdom’s National Institute for Health and Care Excellence (NICE) issues guidance to the National Health Service (NHS) in England, Wales, Scotland and Northern Ireland. NICE guidance does not cover whether or not the NHS should fund a procedure. Local NHS bodies (primary care trusts and hospital trusts) make decisions about funding after considering the clinical effectiveness of the procedure and whether the procedure represents value for money for the NHS.[43]

NICE evaluated TMS for severe depression (IPG 242) in 2007, and subsequently considered TMS for reassessment in January 2011 but did not change its evaluation.[44] The Institute found that TMS is safe, but there is insufficient evidence for its efficacy.[44]

In January 2014, NICE reported the results of an evaluation of TMS for treating and preventing migraine (IPG 477). NICE found that short-term TMS is safe but there is insufficient evidence to evaluate safety for long-term and frequent uses. It found that evidence on the efficacy of TMS for the treatment of migraine is limited in quantity, that evidence for the prevention of migraine is limited in both quality and quantity.[45]

TMS uses electromagnetic induction to generate an electric current across the scalp and skull without physical contact.[46] A plastic-enclosed coil of wire is held next to the skull and when activated, produces a magnetic field oriented orthogonally to the plane of the coil. The magnetic field passes unimpeded through the skin and skull, inducing an oppositely directed current in the brain that activates nearby nerve cells in much the same way as currents applied directly to the cortical surface.[47]

The path of this current is difficult to model because the brain is irregularly shaped and electricity and magnetism are not conducted uniformly throughout its tissues. The magnetic field is about the same strength as an MRI, and the pulse generally reaches no more than 5 centimeters into the brain unless using the deep transcranial magnetic stimulation variant of TMS.[48] Deep TMS can reach up to 6cm into the brain to stimulate deeper layers of the motor cortex, such as that which controls leg motion.[49]

From the BiotSavart law

it has been shown that a current through a wire generates a magnetic field around that wire. Transcranial magnetic stimulation is achieved by quickly discharging current from a large capacitor into a coil to produce pulsed magnetic fields between 2 and 3 T.[50] By directing the magnetic field pulse at a targeted area of the brain, one can either depolarize or hyperpolarize neurons in the brain. The magnetic flux density pulse generated by the current pulse through the coil causes an electric field as explained by the Maxwell-Faraday equation,

This electric field causes a change in the transmembrane current of the neuron, which leads to the depolarization or hyperpolarization of the neuron and the firing of an action potential.[50]

The exact details of how TMS functions are still being explored. The effects of TMS can be divided into two types depending on the mode of stimulation:

MRI images, recorded during TMS of the motor cortex of the brain, have been found to match very closely with PET produced by voluntary movements of the hand muscles innervated by TMS, to 522mm of accuracy.[53] The localisation of motor areas with TMS has also been seen to correlate closely to MEG[54] and also fMRI.[55]

The design of transcranial magnetic stimulation coils used in either treatment or diagnostic/experimental studies may differ in a variety of ways. These differences should be considered in the interpretation of any study result, and the type of coil used should be specified in the study methods for any published reports.

The most important considerations include:

With regard to coil composition, the core material may be either a magnetically inert substrate (i.e., the so-called ‘air-core’ coil design), or possess a solid, ferromagnetically active material (i.e., the so-called ‘solid-core’ design). Solid core coil design result in a more efficient transfer of electrical energy into a magnetic field, with a substantially reduced amount of energy dissipated as heat, and so can be operated under more aggressive duty cycles often mandated in therapeutic protocols, without treatment interruption due to heat accumulation, or the use of an accessory method of cooling the coil during operation. Varying the geometric shape of the coil itself may also result in variations in the focality, shape, and depth of cortical penetration of the magnetic field. Differences in the coil substance as well as the electronic operation of the power supply to the coil may also result in variations in the biophysical characteristics of the resulting magnetic pulse (e.g., width or duration of the magnetic field pulse). All of these features should be considered when comparing results obtained from different studies, with respect to both safety and efficacy.[56]

A number of different types of coils exist, each of which produce different magnetic field patterns. Some examples:

Design variations in the shape of the TMS coils allow much deeper penetration of the brain than the standard depth of 1.52.5cm. Circular crown coils, Hesed (or H-core) coils, double cone coils, and other experimental variations can induce excitation or inhibition of neurons deeper in the brain including activation of motor neurons for the cerebellum, legs and pelvic floor. Though able to penetrate deeper in the brain, they are less able to produce a focused, localized response and are relatively non-focal.[7]

Luigi Galvani did pioneering research on the effects of electricity on the body in the late 1700s, and laid the foundations for the field of electrophysiology.[58] In the 1800s Michael Faraday discovered that an electrical current had a corresponding magnetic field, and that changing one, could change the other.[59] Work to directly stimulate the human brain with electricity started in the late 1800s, and by the 1930s electroconvulsive therapy has been developed by Italian physicians Cerletti and Bini.[58] ECT became widely used to treat mental illness and became overused as it began to be seen as a “psychiatric panacea”, and a backlash against it grew in the 1970s.[58] Around that time Anthony T. Barker began exploring use of magnetic fields to alter electrical signalling in the brain, and the first stable TMS devices were developed around 1985.[58][59] They were originally intended as diagnostic and research devices, and only later were therapeutic uses explored.[58][59] The first TMS devices were approved by the FDA in October 2008.[58]

TMS research in animal studies is limited due to early FDA approval of TMS treatment of drug-resistant depression. Because of this, there has been no specific coils for animal models. Hence, there are limited number of TMS coils that can be used for animal studies.[60] There are some attempts in the literature showing new coil designs for mice with an improved stimulation profile.[61]

Areas of research include:

It is difficult to establish a convincing form of “sham” TMS to test for placebo effects during controlled trials in conscious individuals, due to the neck pain, headache and twitching in the scalp or upper face associated with the intervention.[4][7] “Sham” TMS manipulations can affect cerebral glucose metabolism and MEPs, which may confound results.[74] This problem is exacerbated when using subjective measures of improvement.[7] Placebo responses in trials of rTMS in major depression are negatively associated with refractoriness to treatment, vary among studies and can influence results.[75]

A 2011 review found that only 13.5% of 96 randomized control studies of rTMS to the dorsolateral prefrontal cortex had reported blinding success and that, in those studies, people in real rTMS groups were significantly more likely to think that they had received real TMS, compared with those in sham rTMS groups.[76] Depending on the research question asked and the experimental design, matching the discomfort of rTMS to distinguish true effects from placebo can be an important and challenging issue.[4][7][8][9]

Follow this link:

Transcranial magnetic stimulation – Wikipedia

Posted in Tms

Hope Peace Recovery Treatment Centers – What is TMS therapy?

At Hope Peace Recovery Center, we can help give back what depression has taken away from you. Healthy relationships, physical energy, quality of lifeeveryones list is different. But the first thing we give back to all our patients is hope. Hope in a treatment thats truly unique. Hope in long-lasting results. Hope in remission.

What is TMS?Testimonials

More here:

Hope Peace Recovery Treatment Centers – What is TMS therapy?

Posted in Tms

12345...10...